Skip to main content

Reporter Jan 20 2017

Flu vaccine response in older adults

Jan. 25, 2017—High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.

Read more


Saliva test for obesity risk

Jan. 24, 2017—“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.

Read more


Improving vaccine formulations

Jan. 20, 2017—The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.

Read more


Colorectal cancer clues

Jan. 19, 2017—Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways.

Read more


VICC joins cancer genomic data sharing initiative

Jan. 19, 2017—Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.

Read more


Digestive Disease Research Center lands major grant

Jan. 19, 2017—The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.

Read more


MLK lecturer sees teamwork as crucial to health care diversity

Jan. 19, 2017—David Gordon, M.D., dean of the University of Akron College of Health Professions, gave the 2017 Martin Luther King Jr. Commemorative Lecture on Monday at Vanderbilt, touching on the theme of teamwork as it relates to health care diversity.

Read more


Surprising finding by VU team sheds light on fibrotic disease

Jan. 19, 2017—Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.

Read more


COX-2 ‘conjugate’ may slow growth of some tumors: study

Jan. 19, 2017—More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

Read more


Newly available infographic shows vast scope of EpicLeap program

Jan. 19, 2017—“EpicLeap by the Numbers” is a recently created infographic that gathers, in one place, an array of data points that demonstrate the remarkable magnitude of the EpicLeap program.

Read more


Study to track diabetes drug’s ability to also treat asthma

Jan. 19, 2017—Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.

Read more


Garraway creates scholarship in honor of Levi Watkins Jr.

Jan. 19, 2017—Annie Marie Garraway, Ph.D., has created the Levi Watkins Jr., M.D. Scholarship in honor of her late brother, Levi Watkins Jr., M.D.

Read more


Page 1 of 212

Upcoming Events

MORE EVENTS »

Recent Stories from VUMC News and Communications Publications

Combating cancer disparities is an out-of-office assignment for Claudia Barajas

Momentum

Combating cancer disparities is an out-of-office assignment for Claudia Barajas

Beyond the walls

Hope

Beyond the walls

Spotlight bladder cancer

Momentum

Spotlight bladder cancer

Life goes on

Vanderbilt Medicine

Life goes on

more